Home › Research › Prevention and risk
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis
Myran DT, Pugliese M, Harrison LD, Stall NM, Webber C. JAMA Neurology, 2025-06-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Importance Cannabis use is associated with short-term memory impairment and long-term changes in brain structure; however, little is known about whether disordered cannabis use is associated with an increased risk of a dementia diagnosis. Results The study included 6 086 794 individuals, of whom 16 275 (0.3%) had incident acute care due to cannabis use (mean age, 55.2 [SD, 8.3] years; 60.3% male). Individuals with incident acute care due to cannabis use were at a 1.5-fold and 3.9-fold increased risk of dementia diagnosis within 5 years relative to individuals with all-cause acute care and the general population of the same age and sex, respectively (absolute rates of dementia diagnosis: 5.0% for cannabis-related acute care, 3.6% for all-cause acute care, and 1.3% in the general population). Individuals with acute care due to cannabis use were at lower risk than those with acute care due to alcohol use (aHR, 0.69; 95% CI, 0.62-0.76). Conclusions and relevance Individuals with cannabis use severe enough to require hospital-based care were at increased risk of a new dementia diagnosis compared with those with all-cause hospital-based care or the general population. These findings have important implications considering increasing cannabis use among older adults.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 6,086,794 participants. This cohort study found that people with cannabis use severe enough to require hospital-based care had a higher risk of a new dementia diagnosis than those with all-cause hospital care or the general population. Reported effect size: Adjusted HR 1.23 (95% CI 1.09-1.39) vs all-cause acute care; 1.72 (95% CI 1.38-2.15) vs general population.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Myran, D. T., Pugliese, M., Harrison, L. D., Stall, N. M., & Webber, C. (2025). Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2025.0530
Vancouver
Myran DT, Pugliese M, Harrison LD, Stall NM, Webber C. Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis. JAMA Neurology. 2025. doi:10.1001/jamaneurol.2025.0530. PMID: 40227745.
BibTeX
@article{myran2025-40227745,
author = {Myran, D. T. and Pugliese, M. and Harrison, L. D. and Stall, N. M. and Webber, C.},
title = {{Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis}},
journal = {JAMA Neurology},
year = {2025},
doi = {10.1001/jamaneurol.2025.0530},
pmid = {40227745},
url = {https://doi.org/10.1001/jamaneurol.2025.0530}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Importance Cannabis use is associated with short-term memory impairment and long-term changes in brain structure; however, little is known about whether disordered cannabis use is associated with an increased risk of a dementia diagnosis.
- Results The study included 6 086 794 individuals, of whom 16 275 (0.3%) had incident acute care due to cannabis use (mean age, 55.2 [SD, 8.3] years; 60.3% male).
- Individuals with incident acute care due to cannabis use were at a 1.5-fold and 3.9-fold increased risk of dementia diagnosis within 5 years relative to individuals with all-cause acute care and the general population of the same age and sex, respectively (absolute rates of dementia diagnosis: 5.0% for cannabis-related acute care, 3.6% for all-cause acute care, and 1.3% in the general population).
- Individuals with acute care due to cannabis use were at lower risk than those with acute care due to alcohol use (aHR, 0.69; 95% CI, 0.62-0.76).
- Conclusions and relevance Individuals with cannabis use severe enough to require hospital-based care were at increased risk of a new dementia diagnosis compared with those with all-cause hospital-based care or the general population.
Why it matters
This cohort study found that people with cannabis use severe enough to require hospital-based care had a higher risk of a new dementia diagnosis than those with all-cause hospital care or the general population. The study was observational and cannot show that cannabis use causes dementia.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designcohort
- Participants6,086,794
- Effect sizeAdjusted HR 1.23 (95% CI 1.09-1.39) vs all-cause acute care; 1.72 (95% CI 1.38-2.15) vs general population
- Evidence strengthModerate
Limitations
Observational; only captures problematic use severe enough to require hospital care; cannabis users may differ in unmeasured ways; reverse causation (early dementia leading to problematic use) possible.
How this study scored 61/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 60 of the 98 points we could judge it on, which is 61 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Neurology) |
| Journal's citation record | 2 / 4 | JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 6,086,794 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 13 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 6.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 13 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Colleen Webber: h-index 17 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Toronto: institution h-index 1,923 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40227745) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 60 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 60 of the 98 points we could judge it on is 61 out of 100. |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamaneurol.2025.0530
- PubMed: 40227745
- Original source →
- Free full text: PubMed Central →
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention and risk from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.